Published in Ann Allergy Asthma Immunol on January 01, 2005
Tolerance of nonsteroidal anti-inflammatory drug-sensitive patients to the highly specific cyclooxygenase 2 inhibitors rofecoxib and valdecoxib. Ann Allergy Asthma Immunol (2005) 1.06
Safety of the new selective cyclooxygenase type 2 inhibitors rofecoxib and celecoxib in patients with anaphylactoid reactions to nonsteroidal anti-inflammatory drugs. Ann Allergy Asthma Immunol (2004) 0.99
Short-term and long-term tolerability of rofecoxib in patients with prior reactions to nonsteroidal anti-inflammatory drugs. Ann Allergy Asthma Immunol (2005) 0.98
Guidelines for the diagnosis and management of food allergy in the United States: report of the NIAID-sponsored expert panel. J Allergy Clin Immunol (2010) 5.55
Guidelines for the Diagnosis and Management of Food Allergy in the United States: Summary of the NIAID-Sponsored Expert Panel Report. J Allergy Clin Immunol (2010) 2.98
Aspirin-induced asthma: advances in pathogenesis, diagnosis, and management. J Allergy Clin Immunol (2003) 2.26
Improvement of aspirin-intolerant asthma by montelukast, a leukotriene antagonist: a randomized, double-blind, placebo-controlled trial. Am J Respir Crit Care Med (2002) 1.90
Aspirin challenge and desensitization for aspirin-exacerbated respiratory disease: a practice paper. Ann Allergy Asthma Immunol (2007) 1.77
The blocking effect of essential controller medications during aspirin challenges in patients with aspirin-exacerbated respiratory disease. Ann Allergy Asthma Immunol (2005) 1.69
Food allergy: a practice parameter update-2014. J Allergy Clin Immunol (2014) 1.60
Excess dampness and mold growth in homes: an evidence-based review of the aeroirritant effect and its potential causes. Allergy Asthma Proc (2007) 1.51
Aspirin-exacerbated respiratory disease: evaluation and management. Allergy Asthma Immunol Res (2010) 1.19
Guidelines for the diagnosis and management of food allergy in the United States: summary of the NIAID-sponsored expert panel report. Nutr Res (2011) 1.14
The natural history and clinical characteristics of aspirin-exacerbated respiratory disease. Ann Allergy Asthma Immunol (2002) 1.14
Long-term treatment with aspirin desensitization in asthmatic patients with aspirin-exacerbated respiratory disease. J Allergy Clin Immunol (2003) 1.12
The safety of celecoxib in patients with aspirin-sensitive asthma. Arthritis Rheum (2002) 1.09
Selection of aspirin dosages for aspirin desensitization treatment in patients with aspirin-exacerbated respiratory disease. J Allergy Clin Immunol (2006) 1.00
The united allergic airway: connections between allergic rhinitis, asthma, and chronic sinusitis. Am J Rhinol Allergy (2012) 0.98
Aspirin sensitivity: implications for patients with coronary artery disease. JAMA (2004) 0.97
Effect of leukotriene modifier drugs on the safety of oral aspirin challenges. Ann Allergy Asthma Immunol (2006) 0.96
Predicting outcomes of oral aspirin challenges in patients with asthma, nasal polyps, and chronic sinusitis. Ann Allergy Asthma Immunol (2008) 0.95
Guidelines for the diagnosis and management of food allergy in the United States: summary of the NIAID-Sponsored Expert Panel Report. Nutrition (2011) 0.92
Selection of patients for aspirin desensitization treatment. J Allergy Clin Immunol (2006) 0.90
Early effects of aspirin desensitization treatment in asthmatic patients with aspirin-exacerbated respiratory disease. Ann Allergy Asthma Immunol (2003) 0.87
Use of intranasal ketorolac and modified oral aspirin challenge for desensitization of aspirin-exacerbated respiratory disease. Ann Allergy Asthma Immunol (2010) 0.86
Sensitivity to nonsteroidal anti-inflammatory drugs. Ann Allergy Asthma Immunol (2002) 0.86
Aspirin-exacerbated respiratory disease: burden of disease. Allergy Asthma Proc (2012) 0.85
Rational approach to aspirin dosing during oral challenges and desensitization of patients with aspirin-exacerbated respiratory disease. J Allergy Clin Immunol (2008) 0.85
Guidelines for the diagnosis and management of food allergy in the United States: summary of the NIAID-Sponsored Expert Panel report. J Am Acad Dermatol (2011) 0.85
The relationship between historical aspirin-induced asthma and severity of asthma induced during oral aspirin challenges. J Allergy Clin Immunol (2007) 0.83
An epidemic of over diagnosing drug allergies. Allergy Asthma Proc (2014) 0.83
Clopidogrel desensitization after drug-eluting stent placement. J Am Coll Cardiol (2007) 0.83
The clinical dilemma of "silent desensitization" in aspirin-exacerbated respiratory disease. Allergy Asthma Proc (2013) 0.82
Aspirin-exacerbated respiratory disease: update on pathogenesis and desensitization. Semin Respir Crit Care Med (2012) 0.81
Failure to maintain an aspirin-desensitized state in a patient with aspirin-exacerbated respiratory disease. Ann Allergy Asthma Immunol (2006) 0.79
Safety of high-dose rofecoxib in patients with aspirin-exacerbated respiratory disease. Ann Allergy Asthma Immunol (2004) 0.78
Does it make sense to "desens"? Aspirin desensitization in the treatment of chronic rhinosinusitis. Curr Allergy Asthma Rep (2006) 0.78
Cardiovascular prophylaxis and aspirin "allergy". Immunol Allergy Clin North Am (2012) 0.78
Classification of reactions to nonsteroidal antiinflammatory drugs. Immunol Allergy Clin North Am (2012) 0.77
The Difficult-to-Control Asthmatic: A Systematic Approach. Allergy Asthma Clin Immunol (2006) 0.77
Does suppression of IL-4 synthesis by aspirin explain the therapeutic benefit of aspirin desensitization treatment? J Allergy Clin Immunol (2010) 0.77
Making the call: the diagnosis of acute community-acquired bacterial sinusitis. Am J Rhinol (2006) 0.77
Aspirin desensitization in aspirin-exacerbated respiratory disease. Immunol Allergy Clin North Am (2012) 0.77
Supraesophageal reflux disease: a review of the literature. Allergy Asthma Proc (2014) 0.77
Aspirin as a cause of pancreatitis in patients with aspirin-exacerbated respiratory disease. J Allergy Clin Immunol (2012) 0.76
Smoking, environmental tobacco smoke, and aspirin-exacerbated respiratory disease. Ann Allergy Asthma Immunol (2011) 0.76
Failure of tacrolimus to prevent aspirin-induced respiratory reactions in patients with aspirin-exacerbated respiratory disease. J Allergy Clin Immunol (2005) 0.76
Side effects from daily aspirin treatment in patients with AERD: Identification and management. Allergy Asthma Proc (2011) 0.75
Hydroxyurea in the treatment of Churg-Strauss syndrome. J Allergy Clin Immunol (2009) 0.75
Aspirin-exacerbated respiratory disease: is it in our DNA? Ann Allergy Asthma Immunol (2011) 0.75
Evidence-based protocols for oral NSAID challenges. J Pediatr (2006) 0.75
Role of aspirin and other nonsteroidal anti-inflammatory drugs in aspirin-exacerbated respiratory disease. Expert Rev Clin Immunol (2006) 0.75
Approach to patients with aspirin hypersensitivity and acute cardiovascular emergencies. Allergy Asthma Proc (2013) 0.75
Methicillin-resistant Staphylococcus aureus pelvic abscesses in a female after gynecologic pelvic surgery. Am J Obstet Gynecol (2011) 0.75
Sinusitis and chronic progressive exercise-induced cough and dyspnea. Allergy Asthma Proc (2009) 0.75
Characterization of aspirin allergies in patients with coronary artery disease. Ann Allergy Asthma Immunol (2013) 0.75
Assessment of sensitization risk of a laundry pre-spotter containing protease. Cutan Ocul Toxicol (2011) 0.75
Macrolide antibiotics as anti-inflammatory agents. Curr Allergy Asthma Rep (2005) 0.75
Nonsteroidal anti-inflammatory drug-induced reactions and desensitization. J Asthma (2004) 0.75